World Investment Advisors Sells 2,155 Shares of Cigna Group $CI

World Investment Advisors lowered its holdings in Cigna Group (NYSE:CI) by 27.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,698 shares of the health services provider’s stock after selling 2,155 shares during the quarter. World Investment Advisors’ holdings in Cigna Group were worth $1,568,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CI. Wilkerson Advisory Group LLC acquired a new position in Cigna Group during the fourth quarter worth $25,000. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group during the fourth quarter valued at about $28,000. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group during the fourth quarter worth about $29,000. Prosperity Bancshares Inc acquired a new stake in shares of Cigna Group in the 4th quarter worth about $29,000. Finally, Lodestone Wealth Management LLC acquired a new stake in shares of Cigna Group in the 4th quarter worth about $32,000. Institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Cigna Group Trading Up 0.1%

Shares of CI stock opened at $279.63 on Friday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company has a 50-day simple moving average of $283.79 and a two-hundred day simple moving average of $278.33. The company has a market capitalization of $73.97 billion, a price-to-earnings ratio of 11.85, a PEG ratio of 1.08 and a beta of 0.28.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same quarter last year, the business posted $6.74 EPS. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on CI. UBS Group lifted their price target on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Morgan Stanley boosted their price objective on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Piper Sandler dropped their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Guggenheim raised their target price on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $338.30.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.